Although ketamine inhibits ATP-sensitive K (KATP) channels in rat ventricular myocytes and abolishes the cardioprotective effect of ischemic preconditioning in isolated rat hearts and in rabbits in in vivo, no studies to date specifically address the precise mechanism of this prevention of ischemic preconditioning by ketamine. This study investigated the mechanism of the blockade of ischemic preconditioning by ketamine in rabbit ventricular myocytes using patch-clamp techniques and in rabbit heart slices model for simulated ischemia and preconditioning. In cell-attached and inside-out patches, ketamine inhibited sarcolemmal KATP channel activities in a concentration-dependent manner. Ketamine decreased the burst duration and increased the interburst duration without a change in the single-channel conductance. In the heart slice model of preconditioning, heart slices preconditioned with a single 5-min anoxia, pinacidil, or diazoxide, followed by 15-min reoxygenation, were protected against subsequent 30-min anoxia and 1-h reoxygenation, and the cardioprotection was blocked by the concomitant presence of ketamine. These data are consistent with the notion that inhibition of sarcolemmal or mitochondrial KATP channels may contribute, at least in part, to the mechanism of the blockade of ischemic preconditioning by ketamine. cardioprotective effect; heart slices ACTIVATION of the ATP-sensitive K ϩ (K ATP ) channels may be an endogenous protective mechanism against cardiac damage during myocardial ischemia (9). K ATP channels have been also known to play an important role in ischemic preconditioning (21); brief periods of prior ischemia protect the heart against subsequent prolonged ischemia (16). It was suggested recently that mitochondrial rather than sarcolemmal K ATP channels might be primarily responsible for the cardioprotection of ischemic preconditioning (18, 28) .
cardioprotective effect; heart slices ACTIVATION of the ATP-sensitive K ϩ (K ATP ) channels may be an endogenous protective mechanism against cardiac damage during myocardial ischemia (9) . K ATP channels have been also known to play an important role in ischemic preconditioning (21) ; brief periods of prior ischemia protect the heart against subsequent prolonged ischemia (16). It was suggested recently that mitochondrial rather than sarcolemmal K ATP channels might be primarily responsible for the cardioprotection of ischemic preconditioning (18, 28) .
Ketamine was shown to block K ATP channels in rat ventricular myocytes (13) . The importance of this observation, with respect to a potential link between K ATP channel activation and ischemic preconditioning, is that ketamine may inhibit the cardioprotective effects of K ATP channels, presenting a potential peril to patients who have coronary artery disease and are undergoing a variety of surgical procedures. In the preceding studies of this issue, ketamine abolished the cardioprotection induced by preconditioning in isolated rat hearts (14) and in rabbit hearts in vivo (15) . However, no studies to date specifically address the precise mechanism of this prevention of ischemic preconditioning by ketamine. Furthermore, even if one might speculate that ketamine may block ischemic preconditioning via inhibition of K ATP channels, the relevance and specificity of these channels have not been clarified.
Therefore, the purpose of this study was to determine whether ketamine exerts a direct effect on K ATP channels in isolated rabbit ventricular myocytes, and to determine whether ketamine prevents ischemic preconditioning via K ATP channel inhibition in rabbit heart slices model of simulated myocardial ischemia and reperfusion. Specifically, we investigated whether ketamine can prevent mitochondrial K ATP channelinduced preconditioning.
In the present study, we confirmed that ketamine inhibits K ATP channel activities in cell-attached and inside-out patches of rabbit ventricular myocytes. We also found that ketamine inhibited the cardioprotective effect of preconditioning by anoxia, pinacidil, and diazoxide. Our results provide first direct evidence that ketamine prevents ischemic preconditioning via inhibition of sarcolemmal or mitochondrial K ATP channels.
MATERIALS AND METHODS

Heart Preparation
Single ventricular myocytes were isolated from rabbit hearts by enzymatic dissociation procedure as discussed previously (8) . Briefly, in accordance with national guidelines, rabbits weighing 150-280 g were anesthetized with pentobarbital sodium (50 mg/ml, 1 ml/kg body wt) and heparin (300 IU/ml). After adequate anesthesia was achieved, a sternostomy was performed and the heart exposed. Artificial perfusion of the heart was established by cannulation of the aorta. The heart was then removed and placed in a Langen-dorff perfusion apparatus, and an enzymatic method was used for isolation of single ventricular cells for electrophysiological experiments. Alternatively, the hearts were used for the measurement of malondialdehyde (MDA) content and lactate dehydrogenase (LDH) release (described in Measurement of MDA Content and LDH Release).
Electrophysiological Recording and Data Analysis
Single-channel currents were measured in the cell-attached and inside-out patch configurations of the patchclamp technique (6) . Electrodes were fabricated from Clark PG 150T glass (Clark Electromedical Instruments; Pangbourne, UK) in two steps on a Narishige PP-83 electrode puller (Narishige; Tokyo, Japan). Electrodes were fire polished to a final tip resistance between 7 and 13 M⍀ after being coated with Sylgard (Dow Corning; Midland, MI). Channel activity was measured using a patch-clamp amplifier (Axopatch-1D, Axon Instruments; Union City, CA). The DAD-12 superfusion system (Adams and List Associates, New York) was used for the rapid change (within 100 ms) of bath solution and drugs in most experiments. Experiments were done at a room temperature of 25 Ϯ 2°C. Data were stored in digitized format on digital audiotapes using a DTR-1200 recorder (Biologic; Grenoble, France). For the analysis of single channel activity, the data were transferred to a computer (IBM-PC, Pentium-III 450; Busan, Korea) with pCLAMP (version 6.3 software, Axon Instruments) through an analog-to-digital converter interface (Digidata-1200, Axon Instruments) at a sampling rate of 0.4-20 kHz and filtered at 0.1-10 kHz using a low-pass Bessel filter.
Channel activity. The threshold for judging the open-state K ATP channels was set at half single channel amplitude. The open probability (Po) was calculated using the formula
where tj is the time spent at current levels corresponding to j ϭ 0, 1, 2,. . ., N (superscript) channels in the open state, Td is the duration of the recording, and N is the number of channels active in the patch. The number of channels in a patch was estimated by dividing the maximum current observed, during an extended period at zero ATP, by the mean unitary current amplitude. P o was calculated over 60-s records. The degree of channel activity was assessed by digitizing segments of current records and expressed as NP o. The ketamine-inhibitory curve was obtained by fitting a conventional Hill function to the experimental data using a nonlinear least-squares method (8) .
Single-channel kinetics. Single-channel kinetics were analyzed with methods following those of Han et al. (8) . Briefly, single-channel recordings showing no obvious overlapped channel activity were used in the analysis. Opening and closing events were detected using a standard one-half amplitude threshold procedure. Dwell-time distribution histograms were constructed from single-channel current recordings of more than 60 s. All currents were filtered at 0.2-5 kHz and digitally sampled at 2-20 kHz. Single or multiexponential fits of the open or closed time distribution histograms were done using Fetchan and P-Stat software programs (Axon Instruments). Bins, corresponding to the time of underestimated events assumed equal to twice the digitization time, were excluded from fitting.
Measurement of MDA Content and LDH Release
Preparation of heart slices. After anesthesia, a dissected heart was mounted on a Langendorff apparatus and perfused retrogradely with oxygenated normal Tyrode solution for 5-6 min until all signs of blood were removed. Thin (0.4-0.5 mm thick) slices of heart were prepared using a Stadie-Riggs microtome and were stored in an ice-cold modified CrossTaggart medium containing (in mM) 130 NaCl, 10 KCl, 1.5 CaCl 2, 5 glucose, and 20 Tris ⅐ HCl (pH 7.4). The average weight of heart slices used was 59.6 Ϯ 2.9 mg (n ϭ 251).
Experimental protocol. The protocols are summarized in Fig. 1 . After the equilibration period (20 min), heart slices were subjected to a 5-min treatment interval (series [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . During this treatment interval, heart slices were alternatively pretreated with 50 M pinacidil (series [13] [14] [15] [16] , 100 M diazoxide (series [17] [18] [19] [20] , or with anoxic preconditioning by bubbling the organ bath with 95% N 2-5% CO2 instead of Fig. 1 . Experimental protocol for rabbit heart slices. Heart slices were equilibrated in a bath for at least 30 min before application of one of the protocols. Excluding time control and vehicle groups (A), all heart slices were made anoxic for 30 min (solid bars). B: nonpreconditioned heart slices were exposed to 30 min anoxia alone. C: in the absence of oxygen, heart slices were underwent anoxic preconditioning alone or in the presence of 50 M glibenclamide, 100 M 5-hydroxydecanoate (5-HD), or 100 M ketamine. D: in the presence of oxygen, heart slices were treated with 50 M pinacidil or 100 M diazoxide in the presence and absence of 50 M glibenclamide, 100 M 5-HD, or 100 M ketamine for 5 min. Time point corresponding to data reported in Fig. 4 and 5 is denoted by arrows. 100% O2 to simulate ischemia (series [8] [9] [10] [11] [12] . These pretreatments were also repeated in the presence of 50 M glibenclamide (series 10, 14, and 18), 100 M 5-hydroxydecanoate (5-HD, series 11, 15, and 19) , or of 100 M ketamine to determine the role of K ATP channels and ketamine (series 12, 16, and 20) . Heart slices that served as time control (series 1) and vehicle (series 2) or those subjected only to the subsequent anoxic insult alone (series 3) received no treatment during this initial 5-min interval. Because glibenclamide, pinacidil, and diazoxide were dissolved in DMSO at a final concentration Ͻ0.1%, the vehicle used for the experiment was physiological solution with DMSO at a final concentration Ͻ0.1%. At the end of the treatment (time: 5 min) and after a washout, a 15-min interval followed during which no treatments were administered. Heart slices in all groups (except series 1 and 2) were then made anoxic by replacing 100% O 2 with 95% N2-5% CO2 in the buffer for 30 min, followed by a 60-min oxygenated period. LDH release and MDA formation were evaluated at the end of the 60-min oxygenated period (time: 110 min).
Measurement of LDH release. For the measurement of LDH release, heart slices were homogenized in 2 ml of distilled water, and the tissue homogenate was centrifuged at 2,000 g for 5 min. The pellet was discarded, and the supernatant was saved. LDH activity was determined in the supernatant and incubation medium using a LDH assay kit (Asan Pharm; Kyunggee-do, Korea). Final values were expressed as a percentage of the total LDH released from heart slices.
Lipid peroxidation assay. Lipid peroxidation measured as MDA was estimated with thiobarbituric acid as previously described (7). In the heart homogenate, the MDA content was expressed per milligram of protein. The protein content was determined according to the method of Bradford (2) . Heart slices were homogenized in an ice-cold 1.15% KCl (5% wt/vol). A 0.2-ml aliquot of homogenate was mixed with 50 l of 8.1% sodium dodecyl sulfate and incubated for 10 min at room temperature. Acetic acid (375 l, 20%, pH 3.5) and 375 l of thiobarbituric acid (0.6%) were added. The mixture was heated for 60 min in a boiling water bath. The samples were allowed to cool at room temperature. After addition of nbutanol and pyridine (15:1, 1.25 ml), the contents were vigorously vortexed and centrifuged at 1,000 rpm for 5 min. The absorbance of the upper colored layer was measured at 535 nm and 520 nm with a spectrophotometer (Hitachi, U-2000) and compared with freshly prepared 1,1,3,3-tetraethoxypropane standards. Final values were expressed as the relative percentage of the control group.
Solutions and Drugs
The normal Tyrode solution contained (in mM) 143 NaCl, 5.4 KCl, 1. The PO 2 was measured using a blood gas analyzer (Nova Stat Profile-3, Nova Bomedical; Waltham, MA). The oxygenation of the incubation medium was maintained by a continuous flow of 100% O 2 to obtain a PO2 between 27.2 and 31.5 kPa. For the induction of simulated anoxia, the medium was bubbled with 95% N 2-5% CO2; the PO2 was ϳ0.23 kPa. The anoxia-reoxygenation experiment carried out at 37°C.
Ketamine was obtained from Yuhan (Seoul, Korea). Pentobarbital sodium was obtained from Hanlim Pharmaceutical (Gyeonggi-do, Korea). All other reagents used in this study were obtained from Sigma (St. Louis, MO). Ketamine and 5-hydroxydecanoate (5-HD) were dissolved directly in experimental solutions for each experiment. 2,4-Dinitrophenol (2,4-DNP), pinacidil, diazoxide, and glibenclamide were dissolved in DMSO, which in its final concentration did not exceed 0.1%. At this concentration, DMSO did not affect the levels of LDH release and MDA formation or K ATP channel activity.
Statistical Analysis
All data are presented as means Ϯ SE. In the patch-clamp studies, the paired Student's t-test was used to compare the significant differences between data sets. In the heart slice studies, statistical analysis was performed by two-way repeated-measures analysis of variance (ANOVA, SuperAnova, Abacus Concepts; Berkeley, CA) for time and treatment (experimental group) effects. If an overall significance between groups was found, comparison was done for the time point (the end of the 60-min reoxygenated period) using either Student's unpaired t-test when two treatment groups were compared or one-way ANOVA, followed by a post hoc Student-Newman-Keuls test. Tests were considered significant when P Ͻ 0.05.
RESULTS
To investigate whether ketamine affects K ATP channel activities in intact ventricular myocytes, we studied the effects of ketamine using the cell-attached configuration ( Fig. 2A, left) . In these experiments, the potential in the patch pipette was held at 0 mV, and thus the membrane potential was held at the resting potential, which was assumed to be about Ϫ70 mV with 5.4 mM K ϩ in the extracellular solution. K ATP channel activity was not observed from cell-attached patches, and only the inward rectifier K ϩ (I K1 ) channels were recorded, which was identified from its current-voltage (I-V) relations showing a slope conductance of about 27 pS for the inward current. After an addition of 2,4-DNP (0.2 mM) in bath solution, I K1 channel depressed gradually, and K ATP channels having large amplitude were activated within 5 min. The I-V relations for such a channel showed a mean singlechannel conductance of about 77 pS and the reversal potential of ϩ70 mV in cell-attached patches, recorded with high KCl concentration solution in the pipette and high NaCl concentration solution in the bath (data not shown). The result suggests that inhibition of ATP synthesis by 2,4-DNP results in the channel activation in the cell-attached patch. In this patch, at least six channel levels were revealed after exposure to 2,4-DNP. Under these experimental conditions, the effect of ketamine on the development of K ATP channel was tested. In the continuous presence of 0.2 mM 2,4-DNP, addition of 1 mM ketamine reduced NP o from 1.25 to 0.25. After washout of ketamine, a dramatic increase in channel activity was observed (NP o ϭ 1.47). The channel induced by 2,4-DNP was inhibited by 50 M glibenclamide, indicating that it was the K ATP channel. The same result was observed in all examined patches (n ϭ 15; Fig. 2A, right) .
We also studied whether ketamine could inhibit K ATP channels directly from the intracellular side of ventricular myocytes. When inside-out patches were formed in the ATP-free solution, the activation of the K ATP channel was observed (Fig. 2B, left) . K ATP channel activity was rapidly and reversibly inhibited by 500 M ATP. The application of 1 mM ketamine to the bath induced a marked and reversible decrease in K ATP channel activity. NP o was reduced from 2.25 to 0.15. This inhibition by ketamine was partially reversible after removal of ketamine (NP o ϭ 1.42). The same result was observed in 19 other patches (Fig. 2B, right) . Figure 3A shows the concentration-dependent effects of ketamine on K ATP channel activity. Ketamine inhibited K ATP channel activity at a concentration starting as low as 1 M and exhibited further inhibitory effects in a concentration-dependent manner. K ATP channel activity was maximally inhibited by 1 mM ketamine. To obtain the internal solution concentration of ketamine ([ketamine] i )-K ATP channel activity relationship, we determined the effect of one concentration of ketamine from each inside-out patch (Fig. 3B) . A plot of relative channel activity as a function of [ketamine] i , using data obtained from a total of 17 patches, was fitted to the Hill equation using the nonlinear leastsquare method as described previously (8) . The open and closed time distributions were analyzed to determine the effect of ketamine on the kinetic properties of the channel (Fig. 3C) . Ketamine (50 M) had no effect on the fast open and closed kinetics within the burst. In the presence of 50 M ketamine, the exponential time constants of the distribution of open ( o ) and closed times ( c ) were 1.38 and 0.30 ms, respectively. These values were similar to those in the control solution ( o ϭ 1.40 ms and c ϭ 0.31 ms). On the other hand, 50 M ketamine decreased the burst duration and increased the interburst duration. The time constant of the burst duration ( b ) was markedly decreased from 21.01 to 11.58 ms by ketamine. It seems the interburst duration histograms were fitted to two exponential functions. In these histograms, the exponential time constants of both the fast ( c1 ϭ 145 ms) and slow ( c2 ϭ 2,769 ms) components were increased by 50 M ketamine. The values of c1 and c2 were 74 and 293 in the control solution. A quantitative analysis of this and six other patches is shown in Fig. 3D .
To further determine any interaction between the ketamine-induced K ATP channel inhibition and ischemic preconditioning in the heart slice model of simulated myocardial ischemia, the effects of ketamine on the LDH release and lipid peroxidation were evaluated at the end of the 60-min postanoxia in pretreated heart slices with anoxia, pinacidil, or diazoxide. In Figs. 4A and 5A, the LDH release and MDA formation in the time-control group were 7 Ϯ 3% and 220 Ϯ 110 pmol/mg protein, respectively. Vehicle itself did not affect the LDH release and MDA formation under any experimental conditions. In the nonpreconditioned group, the LDH release and MDA formation were significantly increased compared with the time control and vehicle groups. In addition, 50 M glibenclamide, 100 M 5-HD, and 100 M ketamine had no effect on the LDH release and MDA formation. In Figs. 4B and 5B, pretreatment of the heart slices with a single 5-min anoxic interval resulted in a significant reduction in the LDH release and MDA formation. The beneficial effects of 5 min anoxia were prevented by the dose of glibenclamide, 5-HD, and ketamine. Pretreatment with 50 M pinacidil (Figs. 4C and 5C ) or 100 M diazoxide (Figs. 4D and 5D ) also significantly reduced the LDH release and MDA formation to that in the anoxic preconditioning group, with this effect being prevented by glibenclamide, 5-HD, and ketamine, as in the anoxic preconditioning group.
DISCUSSION
Ischemic preconditioning is a phenomenon in which brief episodes of ischemia and reperfusion protect the heart against subsequent lethal ischemia (16). K ATP channels have been proposed to be the end effector of this protection (5, 21) . Several studies of the effects of anesthetics on the K ATP channel activities in the heart have been performed. Volatile anesthetics, including sevoflurane, isoflurane, and desflurane, have been shown to activate K ATP channels and have cardioprotective effects (20, (22) (23) (24) . In contrast, intravenous anesthetics, including ketamine and thiobarbiturates, have been shown to inhibit K ATP channel activities if applied to cell-attached or inside-out patches (13, 26) , suggesting that ketamine and thiobarbiturates may attenuate the cardioprotective effects of K ATP channels during ischemia and reperfusion. These anesthetics should be used with caution in patients at risk for myocardial ischemia during the intraoperative and perioperative period. Induction of anesthesia with ketamine is associated with increase in cardiac output, arterial blood pressure, and heart rate (10) . Because of these cardiovascular-stimulating effects, ketamine is used in all types of anesthesia in patients whose cardiac performance must be maintained or increased. Therefore, it is important to evaluate any interaction between ketamine and ischemic preconditioning. Ko et al. (13) studied the effects of ketamine on single rat ventricular myocytes and reported a concentration-dependent inhibitory effect of ketamine on K ATP channel activities. The present study, using isolated rabbit ventricular myocytes, confirms that ketamine inhibits K ATP channel activities without affecting the channel conductance during simulated ischemia in the cell-attached and inside-out patches. The concentration dependence of ketamine for the K ATP channel inhibition indicates a first-order reversible reaction between a receptor and ketamine molecule. The findings that ketamine has a stereoselective effect on the myocardium (14, 15) provide further evidence that ketamine's actions are receptor mediated. Because the sulfonylurea receptor is the only receptor known to block K ATP channels (5), it may be possible target for ketamine. Taken together, these results suggest that ketamine inhibits the K ATP channel activities in a membrane-delimited manner. In addition, we further investigated the effects of ketamine on the kinetic properties of the channel and found that ketamine decreases the burst duration and increases the interburst duration without affecting the fast open and closed kinetics within burst. Thus it seems that ketamine does not influence the rapid, open, and closed times within the burst. Rather, it may decrease the number of openings within the burst (Fig. 2) and may produce a decrease in the burst durations and an increase in interburst intervals as shown in Fig. 3C , resulting in the decrease in the channel activity. The analysis of amplitude histogram indicated that the channel activity was decreased but the amplitude of unitary current was not affected by ketamine (data not shown).
Ketamine was recently shown to block ischemic preconditioning in isolated rat hearts (14) and in rabbits in vivo (15) . On the basis of these findings, however, it is not possible to determine the exact mechanism of the blockade of ischemic preconditioning by ketamine. Although one might assume that K ATP channels are most likely involved in the effects of ketamine on ischemic preconditioning from the findings that activation of K ATP channels is involved in the cardioprotection induced by ischemic preconditioning (21, 25) and that ketamine also blocks the K ATP channels in isolated cells (13) , there is no direct evidence linking ketamine and K ATP channel in ischemic preconditioning. In the present study, several lines of evidence indicate that ketamine prevents the cardioprotective effect of ischemic preconditioning through K ATP channel inhibition. First, ketamine was able to block the protective effect Fig. 4 . Lactate dehydrogenase (LDH) release of rabbit heart slices 60 min after a 30-min anoxic insult in time control (n ϭ 66 slices), vehicle (n ϭ 14 slices), nonanoxic preconditioning (non-AP) (n ϭ 58 slices), non-AP with vehicle (n ϭ 10 slices), non-AP with glibenclamide (Glib, 50 M, n ϭ 10 slices), non-AP with 5-HD (100 M, n ϭ 10 slices), non-AP with ketamine (n ϭ 12 slices), AP with vehicle (n ϭ 10 slices), AP (n ϭ 54 slices), AP with Glib (n ϭ 48 slices), AP with 5-HD (n ϭ 35 slices), AP with ketamine (n ϭ 75 slices), pinacidil (Pin, 50 M, n ϭ 54 slices), Pin with Glib (n ϭ 25 slices), Pin with 5-HD (n ϭ 55 slices), Pin with ketamine (n ϭ 67 slices), diazoxide (Diaz, 100 M, n ϭ 39 slices), Diaz with Glib (n ϭ 15 slices), Diaz with 5-HD (n ϭ 61), and Diaz with ketamine (n ϭ 42 slices). Heart slices exposed to the preconditioning by AP (B), Pin (C), and Diaz (D) released significantly less LDH compared with nonpreconditioned heart slices (A) where they were exposed to the 30-min anoxia only. Note that the preconditioning-induced protection was blocked by 50 M Glib, 100 M 5-HD, and 100 M ketamine. Data are presented as means Ϯ SE. † P Ͻ 0.05 compared with time control and vehicle. * P Ͻ 0.05 compared with non-AP. #P Ͻ 0.05 compared with AP. NS, differences are not statistically significant. of preconditioning when it was present during the preconditioning anoxia. Second, prior exposure of heart slices to the K ATP channel agonist pinacidil before the prolonged anoxia caused a decrease in the level of hypoxia-induced LDH release and MDA formation. This protective effect of pinacidil was blocked by ketamine. The data provide direct evidence that K ATP channel inhibition is the mechanism of the blockade of ischemic preconditioning by ketamine.
The protection by K ATP channel was initially thought to be via sarcolemmal K ATP channels (12) . However, recent studies have shown that the mitochondrial K ATP channel is responsible for the cardioprotection of ischemic preconditioning (17) ; diazoxide, a selective mitochondrial K ATP channel opener in cardiac myocytes, reduces myocardial injury, and 5-HD, a selective mitochondrial K ATP channel inhibitor, eliminates protection from diazoxide and ischemic preconditioning (21, 27, 29) . In the present study, several lines of evidence indicate that mitochondrial K ATP channel is present and is activated during preconditioning anoxia to mediate its cardioprotective effect and is inhibited by ketamine. First, 5-HD was able to block the protective effect of preconditioning when it was present during the preconditioning anoxia. Second, prior exposure of the heart slices to diazoxide before the prolonged anoxia caused a decrease in the levels of LDH release and MDA formation. Third, the cardioprotective effect of diazoxide was blocked not only by 5-HD but also by ketamine. The results provide first demonstration that ketamine abolishes the cardioprotective effects of ischemic preconditioning through inhibition of mitochondrial K ATP channels. In a different set of experiments, we also observed that intravenous anesthetic pentobarbital sodium prevented the cardioprotection in a manner similar to ketamine (data not shown).
Inherent to models of preconditioning is variability in the methods used to simulate ischemia. In the present study, ischemia was simulated by anoxia, which was achieved by substitution of nitrogen for oxygen. To simulate preconditioning (brief initial preconditioning anoxia), heart slices were exposed to 5 min of anoxia, reoxygenated for 15 min, and then incubated in the presence of continuous anoxia for 30 min to induce injury (second sustained anoxia). Although many studies use a duration of anoxia up to 90 min, 30 min has been used in human models (3, 20) . This anoxic period may result in a reversible injury without cell death. Similar to preconditioning in human models, in this study prior anoxic preconditioning lessened the injury by 30-min anoxia.
The current study demonstrated that heart slices from the rabbit in which preconditioning has been conclusively shown in the intact hearts (1) and in in vivo (15) also exhibited preconditioning. The data provided important insight by indicating that heart slices can be also be preconditioned and that the cardioprotective mechanism of preconditioning may be exerted, at least in part, at the level of the cardiac myocytes in the intact heart and in in vivo. The use of this heart slice model for preconditioning and a protocol identical to that employed in preconditioning of isolated perfused heart or in vivo experiments would facilitate cellular characterization of this phenomenon and enable quantitative determination of the extent of cardioprotection by preconditioning. In addition, there are advantages of this experimental model to investigate the mechanism of the blockade of ischemic preconditioning by ketamine. First, the systemic and most humoral side effects of ketamine on ischemic preconditioning can be excluded. Thus the direct myocardial effect of ketamine on ischemic preconditioning can be assessed. Second, the exact concentrations of ketamine and K ATP channel modulators can be determined. This allows quantification of the extent of cardioprotection or anoxic injury during various interventions.
In this study, ketamine was tested at concentrations ranging from 1 to 1,000 M. In inside-out patches, ketamine inhibited the K ATP channel activities at micromolar range with the half-maximal inhibitory concentration of 78.3 M. Pedraz et al. (19) reported a peak plasma concentration of 63 M after administration of 10 mg/kg ketamine by intravenous bolus injection in the rabbit. The clinical concentrations of ketamine are up to ϳ100 M after induction and 10 M during maintenance of anesthesia (4). Furthermore, the peak plasma concentration of ketamine is 3-60 M (11) when patients are anesthetized with intravenous injection of ketamine 2 mg/kg. Combining our observations and these data, it is clear that the concentrations of ketamine used in this study are of physiological relevance and may be sufficient to inhibit K ATP channels in clinical situations.
In conclusion, the current study demonstrated that ketamine inhibited K ATP channel activities in rabbit ventricular myocytes and blocked the cardioprotective effect of preconditioning by anoxia, pinacidil, or diazoxide in the heart slices of the rabbit at concentrations as they occur during clinical ketamine anesthesia. These data indicate that inhibition of sarcolemmal or mitochondrial K ATP channel may contribute, at least in part, to the mechanism of the blockade of ischemic preconditioning by ketamine. To our knowledge, this is the first study specifically address the mechanism of the blockade of ischemic preconditioning by ketamine.
